JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NETS
3901
DELISTED
Netshoes (Cayman) Limited
NETS
| $490K | ﹤0.01% |
62,031
+53,785
| +652% | +$491K |
2017 Q3
1 quarter
|
|
|
AC
3902
DELISTED
Associated Capital Group
AC
| $489K | ﹤0.01% |
14,399
+13,435
| +1,394% | +$475K |
2015 Q4
8 quarters
|
|
3903
iShares JPMorgan EM Corporate Bond ETF
CEMB
$420M
| $488K | ﹤0.01% |
9,573
-6,934
| -42% | -$356K |
2016 Q4
4 quarters
|
|
3904
Cohen & Steers
CNS
$3.76B
| $488K | ﹤0.01% |
10,302
+2,868
| +39% | +$126K |
2015 Q4
8 quarters
|
|
3905
KraneShares CSI China Internet ETF
KWEB
$4.64B
| $488K | ﹤0.01% |
8,331
+5,737
| +221% | +$333K |
2017 Q2
2 quarters
|
|
|
TWNK
3906
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $487K | ﹤0.01% |
32,865
+21,083
| +179% | +$278K |
2017 Q2
2 quarters
|
|
|
INOV
3907
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $487K | ﹤0.01% |
+32,521
| New | +$517K |
2017 Q4
0 quarters
|
|
|
HABT
3908
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $486K | ﹤0.01% |
50,835
+29,664
| +140% | +$316K |
2017 Q3
1 quarter
|
|
3909
NLI Holdings
NL
$346M
| $485K | ﹤0.01% |
34,045
+18,942
| +125% | +$240K |
2016 Q4
4 quarters
|
|
3910
Rocky Brands
RCKY
$345M
| $484K | ﹤0.01% |
25,597
-6,196
| -19% | -$106K |
2016 Q2
6 quarters
|
|
|
ENDP
3911
CALL
DELISTED
Endo International plc
ENDP
| $484K | ﹤0.01% |
62,500
-87,500
| -58% | -$655K |
2017 Q2
2 quarters
|
|
|
ENDP
3912
PUT
DELISTED
Endo International plc
ENDP
| $484K | ﹤0.01% |
62,500
| – | – |
2017 Q2
2 quarters
|
|
3913
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$405M
| $483K | ﹤0.01% |
25,373
-897
| -3% | -$17K |
2013 Q2
18 quarters
|
|
3914
Motorcar Parts of America
MPAA
$196M
| $482K | ﹤0.01% |
+19,272
| New | +$514K |
2017 Q4
0 quarters
|
|
|
CSW
3915
CSW Industrials
CSW
$4.76B
| $481K | ﹤0.01% |
+10,457
| New | +$493K |
2017 Q4
0 quarters
|
|
3916
Luxfer Holdings
LXFR
$465M
| $481K | ﹤0.01% |
30,429
+24,778
| +438% | +$338K |
2016 Q1
7 quarters
|
|
3917
Bank of N.T. Butterfield & Son
NTB
$2.29B
| $481K | ﹤0.01% |
13,254
+11,604
| +703% | +$432K |
2017 Q3
1 quarter
|
|
3918
Helios Technologies
HLIO
$2.27B
| $480K | ﹤0.01% |
7,415
+5,215
| +237% | +$305K |
2016 Q3
5 quarters
|
|
3919
Orion Group Holdings
ORN
$372M
| $480K | ﹤0.01% |
61,359
-9,499
| -13% | -$70.5K |
2016 Q2
6 quarters
|
|
3920
First Trust Financials AlphaDEX Fund
FXO
$1.03B
| $476K | ﹤0.01% |
15,203
-937
| -6% | -$28.7K |
2013 Q2
18 quarters
|
|
3921
Calix
CALX
$2.2B
| $475K | ﹤0.01% |
+79,780
| New | +$483K |
2017 Q4
0 quarters
|
|
|
JCP
3922
PUT
DELISTED
J.C. Penney Company, Inc.
JCP
| $474K | ﹤0.01% |
150,000
-400,000
| -73% | -$1.29M |
2017 Q1
3 quarters
|
|
3923
CALL
Eastman Chemical
EMN
$7.32B
| $472K | ﹤0.01% |
+5,100
| New | +$463K |
2017 Q4
0 quarters
|
|
3924
World Acceptance Corp
WRLD
$800M
| $469K | ﹤0.01% |
5,811
-71,773
| -93% | -$5.77M |
2016 Q3
5 quarters
|
|
|
PMD
3925
DELISTED
Psychemedics Corporation
PMD
| $468K | ﹤0.01% |
22,758
-7,761
| -25% | -$144K |
2016 Q3
5 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.